We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9147:TSENippon Express Holdings, Inc. Analysis

Data as of 2026-07-17 - not real-time

¥5,385.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nippon Express is trading at ¥5,385, comfortably above its 20‑day (¥5,274), 50‑day (¥5,095.5) and 200‑day (¥3,912.65) simple moving averages, confirming a short‑term bullish price momentum. However, the stock’s trailing P/E of 495.9 versus an industry average of 30.8 and a DCF‑derived fair value of ¥1,533 signal a severe valuation disconnect, placing the share deep in overvalued territory. The company’s dividend yield of 1.84% is supported by a modest payout ratio of 9.3%, indicating sustainable dividend policy despite modest profitability (net margin 0.24%).
Fundamentally, the firm shows low gross (9.5%) and operating margins (2.4%) and a high debt‑to‑equity of 102%, but a forward P/E of 8.7 hints at sharply improving earnings expectations. The low beta (~0.31) and moderate 30‑day volatility (28.6%) suggest limited price swings, while decreasing volume points to waning buying pressure. These mixed signals lead to a cautious stance: technical bullishness is outweighed by extreme overvaluation and balance‑sheet concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key moving averages indicating bullish momentum
  • Decreasing volume reducing short‑term momentum strength
  • Severe overvaluation reflected by trailing P/E and DCF gap

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E of 8.7 suggesting strong earnings upside
  • Sustainable dividend with low payout ratio
  • Low beta and defensive logistics exposure supporting stability

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Fundamental structural challenges: thin margins and high debt
  • Long‑term global logistics demand providing steady cash flow
  • Valuation gap remains wide, limiting upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth1.10%
Profit Margin0.24%
P/E Ratio495.9
ROE0.92%
ROA-0.28%
Debt/Equity102.39
P/B Ratio1.6
Op. Cash Flow¥198.4B
Free Cash Flow¥72.9B
Industry P/E30.8

Technical Analysis

TrendBullish
RSI56.8
Support¥4,961.00
Resistance¥5,606.00
MA 20¥5,274.00
MA 50¥5,095.50
MA 200¥3,912.65
MACDBearish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair Value¥1,532.51
Target Price¥4,788.75
Upside/Downside-11.07%
GradeOvervalued
TypeValue
Dividend Yield1.84%

Risk Assessment

Beta0.31
Volatility28.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.